A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate CancerMichael T. Schweizer, Samuel R. Denmeade, Su Jin Lim et al.|Stem Cells Translational Medicine|2019Cited by 124
A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with <i>FGFR3</i> Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157Noah M. Hahn, Daniel M. Geynisman, Trinity J. Bivalacqua et al.|Clinical Cancer Research|2016Cited by 72